TERT promoter mutations in melanoma survival

Despite advances in targeted therapies, the treatment of advanced melanoma remains an exercise in disease management, hence a need for biomarkers for identification of at risk primary melanoma patients. In this study we aimed to assess the prognostic value of TERT promoter mutations in primary melan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Nagore, Eduardo, Heidenreich, Barbara, Rachakonda, Sívaramakrishna, Garcia-Casado, Zaida, Requena, Celia, Soriano, Virtudes, Frank, Christoph, Traves, Victor, Quecedo, Esther, Sanjuan-Gimenez, Josefa, Hemminki, Kari, Teresa Landi, Maria, Kumar, Rajiv
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238633/
https://ncbi.nlm.nih.gov/pubmed/26875008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.30042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados